Meet our esteemed speakers and faculty

All speakers are required to follow the IMCAS Conflict of Interest Policy in order to ensure the scientific transparency and independence of the program.

The speaker list is constantly updated by our Scientific Secretariat. Come back regularly to check out the latest updates.

Speaker welcome messages

Dr. Ozgur AGLAMIS avatar

Dr. Ozgur AGLAMIS

Gynecologist, Turkey

“World genital aesthetic meeting point !”

Dr. Albina KAJAIA avatar

Dr. Albina KAJAIA

Dermatologist, Georgia

“Dear Colleagues, I am excited to invite you to IMCAS World Congress 2025 in Paris! Join me as I chair sessions on injectables and patient satisfaction and present on innovative topics, including collagen stimulation, biostimulators, and thread technologies. IMCAS is an exceptional platform to exchange knowledge, explore innovations, and connect with peers. Let’s shape the future of aesthetic medicine together. See you in Paris! Warm regards, Dr. Albina Kajaia, MD, PhD”

Prof Jean Paul MENINGAUD avatar

Prof Jean Paul MENINGAUD

Plastic Surgeon, France

“Dear Colleagues, I am excited to announce that I will be presenting at the upcoming International Master Course on Aging Science (IMCAS) in Paris. My presentation, titled "Are Platysmal Transection and Salivary Gland Removal Necessary in Neck Lifting?", will explore the intricacies and efficacy of these surgical techniques within the context of facial rejuvenation. This session will delve into the latest advancements in lifting procedures, focusing on whether traditional approaches are still n”

Dr. Barry DEKEYSER avatar

Dr. Barry DEKEYSER

Anesthesiologist, Belgium

“In my presentation, I will provide physicians with a systematic approach to diagnosing and treating common hair disorders, based on my extensive experience as a practitioner, trainer, and advisor in hair conditions. The role of trichoscopy in diagnostics will be highlighted. Several case studies will be presented, where patients were treated with platelet-rich plasma (PRP) and/or Er:YAG laser therapy. PRP and LASER are two modalities that have garnered significant interest.”

Dr. Gustavo H LEIBASCHOFF avatar

Dr. Gustavo H LEIBASCHOFF

Gynecologist, United States

“Not only do the years make us more adult, but they give us the maturity to be able to discern between what works or not, IMCAS is the place where the doctor finds the information and training that will help him provide better care to her/his patients. And I say this with the authority that 50 years as a doctor and 40 in the world of aesthetic medicine give me (which is a very broad term that includes clinic, surgery, gynecology among other branches of medicine)”

Dr. Patricia APT DRUCK avatar

Dr. Patricia APT DRUCK

Cosmetic Surgeon, Chile

“Dear colleagues, It is my honor to invite you to attend my sessions during the Congress in Paris, where we will delve into the latest advancements in laser technology for facial rejuvenation and effective melasma management. In these talks, I will share my clinical experiences, and the latest technological innovations that are transforming outcomes in aesthetic . Laser skin rejuvenation Thursday 30 Jan 2025 14:30-15:30 How to deal with Melasma Saturday 1 Feb 2025 10:30-12:30”

Dr. Kiran GODSE avatar

Dr. Kiran GODSE

Dermatologist, India

“Welcome to IMCAS Biggest event in aesthetics Learn from the leaders Prof Dr Kiran Godse D Y Patil University Navi Mumbai India”

Dr. Nahla HUNTER avatar

Dr. Nahla HUNTER

Dermatologist, Egypt

“I have been attending and participating in IMCAS Paris for several years But this year it is special as I ll be giving two talks and chairing a session All in my field of interest the injectables and cosmeceuticals. Looking forward to a great and different version of IMCAS ”

Dr. Rachita DHURAT avatar

Dr. Rachita DHURAT

Dermatologist, India

“Cetirizine has demonstrated inhibitory effects on prostaglandin D2 synthesis, a molecule implicated in the pathogenesis of hair follicle miniaturization in AGA. In our case series there was an increase in the hair count as compared to the baseline in 9/9 subjects post 16 weeks of therapy. The mean hair count at week 0 was 139.56 (SE of mean of 13.92) and at 16 weeks was 163.44 (SE of mean of 15.52). Cetirizine presents a potential addition to the therapeutic armamentarium for AGA.”

Discover IMCAS Academy

Follow IMCAS

Need assistance?

Privacy policy Legal information
© 2025 IMCAS International Master Course on Aging Science. All rights reserved.
Processing, please wait...

Error

Please fill out all required fields. Here are the fields that are missing: